Tesla Stock in June 2026: FSD Momentum Meets Semiconductor Ambitions Amid Market Volatility

Despite the optimism, the technology remains firmly in the driver-assistance category. Drivers must remain attentive and are legally responsible for the vehicle at all times . The next major milestone is a potential bloc-wide rollout, which would require a vote by the European Commission Technical Committee on Motor Vehicles clearing a 55% majority .

The Price Rollercoaster: From $435 to $385 in Two Weeks

The regulatory wins did not insulate Tesla from broader market forces. After trading above $435 in late May 2026, TSLA shares experienced a significant pullback driven by a broader tech selloff centered on semiconductor weakness . By June 8, the stock had dipped to around $396, and on June 11 it was trading at approximately $385.50 .

There were moments of relief. On June 8, Tesla shares gained 3.38%, buoyed by a confluence of positive catalysts: the expanding FSD footprint in Europe, JPMorgan's decision to drop its long-standing "underweight" (sell) rating, and the beginning of Tesla's robotaxi service rollout .

JPMorgan's upgrade to "neutral" was particularly symbolic, ending a bearish stance that had been in place since July 2023. The bank cited Tesla's integrated supply chain and its position at the "forefront of physical AI" —a notable shift in tone from one of Wall Street's most persistent Tesla skeptics.

Analyst sentiment overall, however, remains conflicted. The consensus rating is Hold with a mean price target around $404, though some firms see substantial upside tied to robotaxi and AI progress . The stock still trades at a very high valuation, with a P/E ratio around 348, and some analysts argue that much of the AI and robotics optimism is already priced in .

Terafab: Musk's $55 Billion Chip Bet

While Tesla's stock reacted to autonomy news, Elon Musk was opening a new strategic chapter. On June 10–11, he virtually attended ASML's closed-door internal technology conference in a fireside chat with CEO Christophe Fouquet to discuss Terafab, a SpaceX-Tesla joint venture to produce cutting-edge semiconductor chips .

ASML characterized Terafab as a "serious endeavor" . The proposed facility would be built in the US near Giga Texas, require at least $55 billion in investment, and target 2-nanometer chip production for AI, robotics, and space data centers . Musk's attendance at the conference followed a post on X where he called ASML "arguably the greatest company in Europe" .

The market reaction around ASML itself was electric. The Dutch chip-equipment maker's stock surged about 8.7% in early June on the Terafab announcement and the company raised its 2026 revenue guidance to €36–40 billion, citing strong AI-driven demand for its extreme ultraviolet (EUV) lithography tools .

However, not everyone was enthusiastic. A group of disgruntled ASML employees threatened to boycott Musk's appearance, citing his involvement in U.S. politics and what some staff described as "Nazi sympathies," airing grievances on the company's internal communications platform . This internal pushback highlights the reputational risks that increasingly follow Musk into corporate partnerships.

What Comes Next

The coming weeks present several potential catalysts for Tesla's stock. SpaceX's IPO, scheduled for June 12 at a target price of $135 per share and a staggering $1.75 trillion valuation, raises questions about whether capital will flow out of Tesla and into the newly public SpaceX . Some analysts worry about a diversion effect, while others argue the "Musk halo" could lift both stocks.

On the technical side, traders are watching key levels. A close below $380.63 could open the door to a test of long-term support at $356.99, while a settlement above descending channel resistance in the low $450s might signal upward continuation later in the year .

For now, Tesla's story in June 2026 is a balancing act: real regulatory momentum in autonomy, genuine analyst warming, and a bold semiconductor vision—all set against a market that has rapidly rotated away from high-valuation tech names. Whether FSD subscriptions and Terafab ambitions can ultimately justify a multi-trillion-dollar valuation remains the central question for investors.